Biotech News
Biosimilars vs. Generics: Why the Two Are Not Interchangeable
Dr. Nathan PryceA generic copies a small-molecule drug exactly. A biosimilar only comes close, because biology will not allow a perfect copy.
Biotech News
Explore Biotech News coverage from Dark Biotechnology: Dated biotech reporting: readouts, deals, filings and FDA actions.
Dated biotech reporting.
Biotech News
FDA Approves Shionogi's Xocova as First Oral COVID-19 Post-Exposure Prophylaxis
Dr. Nathan PryceThe FDA has approved Shionogi's Xocova (ensitrelvir) as the first oral post-exposure prophylaxis for COVID-19 in adults and adolescents 12 years of age and older, the company announced on June 1,…
Biotech News
Why Biotech Manufacturing Capacity Announcements Are Reshaping U.S. Drug Supply
Ravi IyerEli Lilly said in May 2026 that it will invest an additional $4.5 billion at two of its three Lebanon, Indiana sites, lifting Indiana capital commitments above $21 billion over six years, per the…
Biotech News
Johnson & Johnson Lifts 2026 Outlook After $25.3 Billion Second Quarter
Dr. Nathan PryceJohnson & Johnson reported second-quarter 2026 sales of $25.31 billion, up 6.6% year over year, with Innovative Medicine sales of $16.384 billion, up 7.8% — per the earnings release filed with the SEC…
Biotech News
FDA's Expedited IND Comment Window Nears Close After Gene Therapy Holds
Ravi IyerFDA's public comment window on its proposed Expedited IND pilot program closes July 22, 2026, per a Federal Register notice published June 24. The docket follows a stretch in which clinical holds hit…
Biotech News
What BioNTech's CEO Change Signals About Biotech Leadership Transitions
Dr. Nathan PryceBioNTech's supervisory board appointed Guido Oelkers, chief executive of Swedish Orphan Biovitrum since 2017, as the company's next CEO on August 3, 2026, with the transition complete by February 1,…